#rain

The post 3 Altcoins That Could Reach All-Time Highs This Weekend, July 11-12 appeared on BitcoinEthereumNews.com. Three altcoins enter the weekend within striking distance of record prices. ADI and DeXe (DEXE) already trade in price discovery, while Rain (RAIN) sits about 11% below its all-time high (ATH). The selection follows one criterion. These are the coins closest to their previous peaks, or already above them, and Fibonacci extension targets now define how far each rally could stretch. ADI Clears Every Fibonacci Target, as RSI Hits 93 ADI has run its own bull market since June 16, when it bottomed at the 0.382 Fibonacci retracement near $3.65. The token then broke above its previous peak of $4.56 on June 26. Since then, ADI has cleared all three Fibonacci extension targets at $4.96, $5.46, and $6.02. It trades around $6.25 on KuCoin, up 67.6% in 30 days, as the broader market also pushes higher. ADI daily chart / Source: Tradingview However, two warning signs appear. A violent u

The post Enlivex Stock Hits Record Low as RAIN Treasury Draws Scrutiny appeared on BitcoinEthereumNews.com. Enlivex shares hit an all-time low of $0.42, down 94% over five years on Nasdaq. Enlivex pivoted to a RAIN token treasury in November 2025 and raised over $200M. ZachXBT linked RAIN wallet addresses to accounts tied to Moshe Hogeg in May. Every retail investor who has ever bought shares of Enlivex on the Nasdaq has now lost money. The stock hit an all-time low of $0.42, falling 94% over five years and 30% decline this year alone. From Biotech To Crypto Treasury Enlivex spent years developing clinical therapeutics before abruptly reinventing itself in November 2025 as what it called the world’s first prediction markets digital asset treasury strategy. The company raised over $200 million through a private placement at $1 per share, funded in dollars and USDT, and began accumulating RAIN, a governance token on an Arbitrum-based protocol that it compared to Uniswap for prediction ma

The post Nasdaq arthritis company holding Moshe Hogeg crypto hits all-time low appeared on BitcoinEthereumNews.com. As of 8:19am today in New York, every retail investor who had ever bought shares of Enlivex on the Nasdaq, an arthritis biotech-turned-digital asset treasury (DAT), had lost money. The company bet its balance sheet on the RAIN crypto token that ZachXBT eventually tied to Moshe Hogeg, an Israeli entrepreneur facing a $290 million law enforcement investigation. Shares of Enlivex, which have been trading publicly for 12 years, traded to their all-time low of $0.42 this morning. Investors are slowly losing it all. Hogeg has denied fraud allegations via a spokesperson. The biotech company spent years developing clinical therapeutics. Bizarrely, it then reinvented itself in November 2025 to what it called the “world’s first prediction markets digital asset treasury strategy.” That was a world first — and probably last. The company raised over $200 million through a private plac